researchsolutions.com (RSSS) Kompaniya qiymatining sof foydaga nisbati

Research Solutions Inc. (RSSS) korporativ emblemasi va logotipi

Research Solutions (RSSS) R&D bo'limlari uchun SaaS xizmatlarini ishlab chiqmoqda, bu esa ilmiy nashrlarni qidirishni tezlashtiradi. Kompaniyaning texnologiyalari bilimlar bilan ishlashni optimallashtiradi, bu esa dori vositalarini ishlab chiqish muddatlarini eksponensial ravishda qisqartiradi. Bulutli tizimlarning joriy etilishi hamkorlarga qog'ozga asoslangan ish jarayonlarini bartaraf etishga yordam beradi va ma'lumotlar himoyasini kafolatlaydi. Joriy bozor qiymatining ushbu grafigi ushbu ko'rsatkichlarni tasdiqlaydi, bunda joriy koeffitsient 21.60 ni tashkil etadi.

RSSS Research Solutions: Narxning foydaga nisbati 04.07.2022 - 10.11.2026 oraligʻida

Research Solutions (RSSS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning har tomonlama tahlili:Research Solutions Inc. - RSSS
Research Solutions original mahsuloti

Investorlar ushbu koeffitsiyentdan kelajakdagi foyda o'sish sur'atlariga oid bozor kutuvlarining ko'rsatkichi sifatida foydalanadilar. Ushbu metrika sof foydaning bir birligi tannarxini aniqlab, biznesning kengayish imkoniyatlari uchun to'lanadigan premiumni o'lchaydi. Joriy P/E koeffitsiyentini tahlil qilish orqali aktivning bozor narxining adolatli ekanligini baholash mumkin. Research Solutions (RSSS) uchun ushbu ko'rsatkich bashorat qilinadigan SaaS oqimlari va akademik hamjamiyatning institutsional mijozlari orasidagi yuqori sodiqlik tufayli barqarorlashmoqda.

Muhim raqobatchilar

Narx-foyda multiplikatori VEEV (veeva.com)|Narxning foydaga nisbati Doximity (DOCS)|HQY (HealthEquity Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori WAY (Waystar Inc.)|CorVel Corp. (CRVL) - Kapitalizatsiyaning foydaga nisbati|PRVA - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati huronconsultinggroup.com HURN|CERT: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Omnicell Inc (OMCL)|GDRX (GoodRx Corp) - P/E multiplikatori|P/E multiplikatori Schrodinger Corp|Narxning foydaga nisbati Phreesia, Inc. (PHR)|OMDA (omadahealth.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori EVH (Evolent Health)|HSTM - Narx-foyda koeffitsiyenti|Definitive Healthcare Inc. - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CCSI (Consensus Corp)|AGL (Agilon Health) - Narx-foyda koeffitsiyenti|absci.com - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati So-Young International Inc.|National Research Corp (NRC) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Spok Corp (SPOK)|OPRX - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati TruBridge, Inc. TBRG|simulations-plus.com - Narxning foydaga nisbati|SOPH: Narx-foyda koeffitsiyenti|HCAT - P/E multiplikatori|CCLD (carecloud.com) - Narx-foyda koeffitsiyenti|DLHC: Bozor narxining sof foydaga nisbati|ONMD (OneMedNet Corp) - P/E multiplikatori|scienture.com (SCNX) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Healthcare Triangle, Inc. (HCTI)|ISPC - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Bullfrog AI BFRG|WORX: Narx-foyda multiplikatori|MSPR - Narxning foydaga nisbati|Biznesning o‘zini qoplash muddati iCoreConnect Inc. ICCT|TRxADE HEALTH (MEDS) - Narxning foydaga nisbati|Orgenesis Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati R1 RCM, Inc.|Sharecare Inc (SHCR) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Streamline Health Solutions (STRM)|Biznesning o‘zini qoplash muddati syrahealth.com|Narxning foydaga nisbati Apollo Medical Holdings, Inc. AMEH|Biznesning o‘zini qoplash muddati Model N Inc (MODN)|NextGen - P/E multiplikatori